Appointment New Patient Appointment or 214-645-8300

More Blogs

MedBlog

Amyloidosis

Three parallel advances usher in new age of cardiac amyloidosis care

Cardiac amyloidosis was once considered untreatable. Now, we have effective treatments, less invasive diagnostic tests, and a growing body of research in this complex disease.

Fighting heart failure with ‘Fantastic Four,’ new guidelines

New AHA guidelines highlight the benefits of SGLT2i medications for patients with heart failure and advances in diagnosing and treating ATTR amyloidosis.

AL amyloidosis treatments offer patients hope and potentially a cure

A new, FDA-approved four-drug combo for AL amyloidosis is improving longevity and quality of life dramatically. Ankit Kansagra, M.D., discusses how the medication and a multidisciplinary team of experts can give patients longer, healthier lives.